Nootkatone, an AMPK activator derived from grapefruit, inhibits KRAS downstream pathway and sensitizes non-small-cell lung cancer A549 cells to Adriamycin
ConclusionWe demonstrate for the first time that NKT can sensitize ADR-resistant A549/ADR cells to ADR in vitro and in vivo. Metformin, on the other hand, failed to show any synergistic effect with ADR in A549/ADR cells.Graphical abstract
Source: Phytomedicine - Category: Drugs & Pharmacology Source Type: research
More News: Cancer | Cancer & Oncology | Drugs & Pharmacology | Fortamet | Grapefruit | Liver | Lung Cancer | Metformin | Non-Small Cell Lung Cancer | Urology & Nephrology